Fortis Healthcare Limited announced that based on the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors of the Company on September 13, 2023 has approved the appointment of Mr. Ashok Pandit (DIN: 09279899), as an Additional Director (Non-Executive & Non-Independent) of the Company with effect from September 13, 2023. Mr. Ashok Pandit would hold office upto the date of the ensuing Annual General Meeting of the Company and liable to retire by rotation. However, as per regulation 17(1C) of SEBI LODR, the Company shall ensure that the approval of shareholders for appointment of Mr. Ashok Pandit on the Board of the Company is taken at the next general meeting or within 3 months, whichever is earlier.

Mr. Ashok Pandit, aged 57 years, was appointed Group Chief Strategy and Business Development Officer of IHH Healthcare Berhad (IHH) with effect from 1 August 2021. He is responsible for group strategy, business development, mergers and acquisitions, corporate structuring, investments, and divestments. Ashok joined IHH on May 2021 as Group Chief Special Project Officer.

He has over 28 years of investment banking experience in Asia Pacific. Prior to joining IHH, he was Managing Director, Global Co-Head of Sovereign Wealth and Pension Funds and Head of Financial Sponsor Coverage (Asia Pacific) at Deutsche Bank AG, Singapore. During his 15-year tenure at Deutsche Bank, Mr. Pandit held senior investment banking positions, advising leading global institutions and corporations on capital raising, mergers and acquisitions, and advisory and capital restructuring.